Mesenchymal stromal cells to fight SARS-CoV-2: Taking advantage of a pleiotropic therapy

The devastating global impact of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has prompted scientists to develop novel strategies to fight Coronavirus Disease of 2019 (COVID-19), including the examination of pre-existing treatments for other viral infections in COVID-19 patients....

Descripción completa

Detalles Bibliográficos
Autores principales: Barros, Inês, Silva, António, de Almeida, Luís Pereira, Miranda, Catarina Oliveira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836230/
https://www.ncbi.nlm.nih.gov/pubmed/33397585
http://dx.doi.org/10.1016/j.cytogfr.2020.12.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836230/
https://www.ncbi.nlm.nih.gov/pubmed/33397585
http://dx.doi.org/10.1016/j.cytogfr.2020.12.002

Ejemplares similares